These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Methadone for cancer pain: a case report. Nixon AJ Am J Hosp Palliat Care; 2005; 22(5):337. PubMed ID: 16225353 [No Abstract] [Full Text] [Related]
4. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur? Zimmermann C; Seccareccia D; Booth CM; Cottrell W J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458 [TBL] [Abstract][Full Text] [Related]
5. Getting comfortable with methadone. J Support Oncol; 2003; 1(1):52. PubMed ID: 15352643 [No Abstract] [Full Text] [Related]
6. Use of Very-Low-Dose Methadone and Haloperidol for Pain Control in Palliative Care Patients: Are the Sigma-1 Receptors Involved? Cobos EJ; Baeyens JM J Palliat Med; 2015 Aug; 18(8):660. PubMed ID: 26087240 [No Abstract] [Full Text] [Related]
7. Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone. LeBaron V; Brody J; Lee EM; Hardin C; Snyder L J Pain Palliat Care Pharmacother; 2011; 25(4):356-61. PubMed ID: 22126165 [No Abstract] [Full Text] [Related]
8. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. Mercadante S Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828 [TBL] [Abstract][Full Text] [Related]
9. Methadone:effective analgesia, confusion, and risk. Lipman AG J Pain Palliat Care Pharmacother; 2005; 19(2):3-5. PubMed ID: 16061455 [No Abstract] [Full Text] [Related]
10. The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report. Salpeter SR; Buckley JS; Buckley NS; Bruera E J Palliat Med; 2015 Feb; 18(2):114-9. PubMed ID: 25494475 [TBL] [Abstract][Full Text] [Related]
11. Preliminary Validation for the "BJR method"-A Possible New Mathematical Approach to Methadone Conversion. Trofimovitch D; Hutchinson L; Baumrucker SJ J Pain Palliat Care Pharmacother; 2019; 33(1-2):42-48. PubMed ID: 31260376 [TBL] [Abstract][Full Text] [Related]
12. Conversion from parenteral to oral methadone. González-Barboteo J; Porta-Sales J; Sánchez D; Tuca A; Gómez-Batiste X J Pain Palliat Care Pharmacother; 2008; 22(3):200-5. PubMed ID: 19042849 [TBL] [Abstract][Full Text] [Related]
13. Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes. Reddy S; Fisch M; Bruera E J Pain Symptom Manage; 2004 Oct; 28(4):301-3. PubMed ID: 15471646 [No Abstract] [Full Text] [Related]
14. Palliative care and hospice opioid dosing guidelines with breakthrough pain (BP) doses. Pappagallo M; Dickerson ED; Hulka S Am J Hosp Palliat Care; 2000; 17(6):407-13. PubMed ID: 11886043 [No Abstract] [Full Text] [Related]
16. Intermittent subcutaneous methadone administration in the management of cancer pain. Centeno C; Vara F J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456 [TBL] [Abstract][Full Text] [Related]
17. Methadone: does stigma play a role as a barrier to treatment of chronic pain? Shah S; Diwan S Pain Physician; 2010; 13(3):289-93. PubMed ID: 20495594 [TBL] [Abstract][Full Text] [Related]
18. An alternative low-dose ad libitum schedule for conversion of other opioids to methadone. Cornish CJ; Keen JC Palliat Med; 2003 Oct; 17(7):643-4. PubMed ID: 14594158 [No Abstract] [Full Text] [Related]
19. Consensus guideline on parenteral methadone use in pain and palliative care. Shaiova L; Berger A; Blinderman CD; Bruera E; Davis MP; Derby S; Inturrisi C; Kalman J; Mehta D; Pappagallo M; Perlov E Palliat Support Care; 2008 Jun; 6(2):165-76. PubMed ID: 18501052 [TBL] [Abstract][Full Text] [Related]
20. Opioid rotation from methadone: fraught with difficulties. Bhimji K J Pain Symptom Manage; 2005 Apr; 29(4):334-5. PubMed ID: 15857735 [No Abstract] [Full Text] [Related] [Next] [New Search]